Copyright Reports & Markets. All rights reserved.

Europe Respiratory Inhaler Devices Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Respiratory Inhaler Devices Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Dry Powder Inhaler Market Performance (Volume)
      • 2.1.2 Metered Dose Inhaler Market Performance (Volume)
      • 2.1.3 Nebulizer Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Dry Powder Inhaler Market Performance (Value)
      • 2.1.2 Metered Dose Inhaler Market Performance (Value)
      • 2.1.3 Nebulizer Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Asthma Market Performance (Volume)
      • 3.1.2 COPD Market Performance (Volume)
      • 3.1.3 Pulmonary Arterial Hypertension Market Performance (Volume)
      • 3.1.4 Other Respiratory Disease Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 AstraZeneca
      • 4.1.1 AstraZeneca Profiles
      • 4.1.2 AstraZeneca Product Information
      • 4.1.3 AstraZeneca Respiratory Inhaler Devices Business Performance
      • 4.1.4 AstraZeneca Respiratory Inhaler Devices Business Development and Market Status
    • 4.2 Beximco Pharmaceuticals Ltd.
      • 4.2.1 Beximco Pharmaceuticals Ltd. Profiles
      • 4.2.2 Beximco Pharmaceuticals Ltd. Product Information
      • 4.2.3 Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Business Performance
      • 4.2.4 Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Business Development and Market Status
    • 4.3 Boehringer Ingelheim GmbH
      • 4.3.1 Boehringer Ingelheim GmbH Profiles
      • 4.3.2 Boehringer Ingelheim GmbH Product Information
      • 4.3.3 Boehringer Ingelheim GmbH Respiratory Inhaler Devices Business Performance
      • 4.3.4 Boehringer Ingelheim GmbH Respiratory Inhaler Devices Business Development and Market Status
    • 4.4 Cipla Ltd.
      • 4.4.1 Cipla Ltd. Profiles
      • 4.4.2 Cipla Ltd. Product Information
      • 4.4.3 Cipla Ltd. Respiratory Inhaler Devices Business Performance
      • 4.4.4 Cipla Ltd. Respiratory Inhaler Devices Business Development and Market Status
    • 4.5 GlaxoSmithKline plc
      • 4.5.1 GlaxoSmithKline plc Profiles
      • 4.5.2 GlaxoSmithKline plc Product Information
      • 4.5.3 GlaxoSmithKline plc Respiratory Inhaler Devices Business Performance
      • 4.5.4 GlaxoSmithKline plc Respiratory Inhaler Devices Business Development and Market Status
    • 4.6 Koninklijke Philips N.V.
      • 4.6.1 Koninklijke Philips N.V. Profiles
      • 4.6.2 Koninklijke Philips N.V. Product Information
      • 4.6.3 Koninklijke Philips N.V. Respiratory Inhaler Devices Business Performance
      • 4.6.4 Koninklijke Philips N.V. Respiratory Inhaler Devices Business Development and Market Status
    • 4.7 Merck & Co., Inc.
      • 4.7.1 Merck & Co., Inc. Profiles
      • 4.7.2 Merck & Co., Inc. Product Information
      • 4.7.3 Merck & Co., Inc. Respiratory Inhaler Devices Business Performance
      • 4.7.4 Merck & Co., Inc. Respiratory Inhaler Devices Business Development and Market Status
    • 4.8 OMRON Healthcare Europe B.V.
      • 4.8.1 OMRON Healthcare Europe B.V. Profiles
      • 4.8.2 OMRON Healthcare Europe B.V. Product Information
      • 4.8.3 OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Business Performance
      • 4.8.4 OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Business Development and Market Status
    • 4.9 PARI Medical Holding
      • 4.9.1 PARI Medical Holding Profiles
      • 4.9.2 PARI Medical Holding Product Information
      • 4.9.3 PARI Medical Holding Respiratory Inhaler Devices Business Performance
      • 4.9.4 PARI Medical Holding Respiratory Inhaler Devices Business Development and Market Status
    • 4.10 Teva Pharmaceutical Industries Ltd
      • 4.10.1 Teva Pharmaceutical Industries Ltd Profiles
      • 4.10.2 Teva Pharmaceutical Industries Ltd Product Information
      • 4.10.3 Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Business Performance
      • 4.10.4 Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Europe Respiratory Inhaler Devices Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Europe Respiratory Inhaler Devices Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Europe Respiratory Inhaler Devices Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Europe Respiratory Inhaler Devices Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Respiratory Inhaler Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Germany Respiratory Inhaler Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Germany Respiratory Inhaler Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Germany Respiratory Inhaler Devices Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Respiratory Inhaler Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 UK Respiratory Inhaler Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 UK Respiratory Inhaler Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 UK Respiratory Inhaler Devices Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Respiratory Inhaler Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 France Respiratory Inhaler Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 France Respiratory Inhaler Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 France Respiratory Inhaler Devices Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Respiratory Inhaler Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Russia Respiratory Inhaler Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Russia Respiratory Inhaler Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Russia Respiratory Inhaler Devices Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Respiratory Inhaler Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 Benelux Respiratory Inhaler Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 Benelux Respiratory Inhaler Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 Benelux Respiratory Inhaler Devices Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Respiratory Inhaler Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Italy Respiratory Inhaler Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Italy Respiratory Inhaler Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Italy Respiratory Inhaler Devices Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Respiratory Inhaler Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Spain Respiratory Inhaler Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Spain Respiratory Inhaler Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Spain Respiratory Inhaler Devices Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Respiratory Inhaler Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Respiratory Inhaler Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Respiratory Inhaler Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Respiratory Inhaler Devices Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Europe Respiratory Inhaler Devices Market Performance (Sales Point)

    • 7.1 Europe Respiratory Inhaler Devices Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Europe Respiratory Inhaler Devices Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Europe Respiratory Inhaler Devices Price (USD/Unit) by Regions 2013-2018
    • 7.4 Europe Respiratory Inhaler Devices Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Respiratory Inhaler Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Germany Respiratory Inhaler Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 UK Respiratory Inhaler Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 France Respiratory Inhaler Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Russia Respiratory Inhaler Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 Benelux Respiratory Inhaler Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Italy Respiratory Inhaler Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Respiratory Inhaler Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Respiratory Inhaler Devices Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Asthma Industry
    • 11.2 COPD Industry
    • 11.3 Pulmonary Arterial Hypertension Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Europe Respiratory Inhaler Devices Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Europe Respiratory Inhaler Devices Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Germany Respiratory Inhaler Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 UK Respiratory Inhaler Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 France Respiratory Inhaler Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Russia Respiratory Inhaler Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Benelux Respiratory Inhaler Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Italy Respiratory Inhaler Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Spain Respiratory Inhaler Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Dry Powder Inhaler Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Metered Dose Inhaler Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Nebulizer Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Asthma Sales and and Growth Rate 2019-2024
      • 12.4.3 COPD Sales and and Growth Rate 2019-2024
      • 12.4.4 Pulmonary Arterial Hypertension Sales and and Growth Rate 2019-2024
      • 12.4.5 Other Respiratory Disease Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Europe Respiratory Inhaler Devices Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Europe Respiratory Inhaler Devices Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Respiratory Inhaler Devices for these regions, from 2012 to 2023 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Respiratory Inhaler Devices market competition by top manufacturers/players, with Respiratory Inhaler Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca
    Beximco Pharmaceuticals Ltd.
    Boehringer Ingelheim GmbH
    Cipla Ltd.
    GlaxoSmithKline plc
    Koninklijke Philips N.V.
    Merck & Co., Inc.
    OMRON Healthcare Europe B.V.
    PARI Medical Holding
    Teva Pharmaceutical Industries Ltd

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Dry Powder Inhaler
    Metered Dose Inhaler
    Nebulizer

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Respiratory Inhaler Devices for each application, including
    Asthma
    COPD
    Pulmonary Arterial Hypertension
    Other Respiratory Disease

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now